Brief: Alk-Abello's EURneffy 1 Mg Gets Approval In U.K.
15/06/2026 08:11
BRIEF-Alk-Abello's EURneffy 1 Mg Gets Approval In U.K. June 15 (Reuters) - ALK-Abello A/S ALKb.CO:
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (MHRA) HAS GRANTED MARKETING AUTHORISATION FOR EURNEFFY 1 MG
EURNEFFY 1 MG APPROVED IN UK AS FIRST AND ONLY NEEDLE-FREE ADRENALINE TREATMENT FOR YOUNG CHILDREN AT RISK OF ANAPHYLAXIS
EURNEFFY INDICATED FOR CHILDREN AGED 4 YEARS AND OVER WEIGHING 15 KG TO LESS THAN 30 KG
Further company coverage: [ALKb.CO]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))